102 related articles for article (PubMed ID: 23891553)
1. [Basic aspects of the potential toxicity of anesthetic drugs].
Patkai J; Zana-Taieb E; Didier C; Jarreau PH; Lopez E
Arch Pediatr; 2013 Sep; 20(9):1059-66. PubMed ID: 23891553
[TBL] [Abstract][Full Text] [Related]
2. Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system.
Wang C; Slikker W
Anesth Analg; 2008 Jun; 106(6):1643-58. PubMed ID: 18499593
[TBL] [Abstract][Full Text] [Related]
3. Glutamate signaling and the fetal alcohol syndrome.
Olney JW; Wozniak DF; Jevtovic-Todorovic V; Ikonomidou C
Ment Retard Dev Disabil Res Rev; 2001; 7(4):267-75. PubMed ID: 11754521
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic insights into neurotoxicity induced by anesthetics in the developing brain.
Lei X; Guo Q; Zhang J
Int J Mol Sci; 2012; 13(6):6772-6799. PubMed ID: 22837663
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity.
Dzietko M; Felderhoff-Mueser U; Sifringer M; Krutz B; Bittigau P; Thor F; Heumann R; Bührer C; Ikonomidou C; Hansen HH
Neurobiol Dis; 2004 Mar; 15(2):177-87. PubMed ID: 15006687
[TBL] [Abstract][Full Text] [Related]
6. In the adult CNS, ethanol prevents rather than produces NMDA antagonist-induced neurotoxicity.
Farber NB; Heinkel C; Dribben WH; Nemmers B; Jiang X
Brain Res; 2004 Nov; 1028(1):66-74. PubMed ID: 15518643
[TBL] [Abstract][Full Text] [Related]
7. Use of anesthetic agents in neonates and young children.
Mellon RD; Simone AF; Rappaport BA
Anesth Analg; 2007 Mar; 104(3):509-20. PubMed ID: 17312200
[TBL] [Abstract][Full Text] [Related]
8. Anesthetics and the developing brain.
Yudkowitz FS
Semin Cardiothorac Vasc Anesth; 2010 Mar; 14(1):44-5. PubMed ID: 20472623
[TBL] [Abstract][Full Text] [Related]
9. Anesthetic neurotoxicity--clinical implications of animal models.
Rappaport BA; Suresh S; Hertz S; Evers AS; Orser BA
N Engl J Med; 2015 Feb; 372(9):796-7. PubMed ID: 25714157
[TBL] [Abstract][Full Text] [Related]
10. Review: effects of anesthetics on brain circuit formation.
Wagner M; Ryu YK; Smith SC; Patel P; Mintz CD
J Neurosurg Anesthesiol; 2014 Oct; 26(4):358-62. PubMed ID: 25144504
[TBL] [Abstract][Full Text] [Related]
11. Food and Drug Administration warning on anesthesia and brain development: implications for obstetric and fetal surgery.
Olutoye OA; Baker BW; Belfort MA; Olutoye OO
Am J Obstet Gynecol; 2018 Jan; 218(1):98-102. PubMed ID: 28888583
[TBL] [Abstract][Full Text] [Related]
12. Correlating the clinical actions and molecular mechanisms of general anesthetics.
Solt K; Forman SA
Curr Opin Anaesthesiol; 2007 Aug; 20(4):300-6. PubMed ID: 17620835
[TBL] [Abstract][Full Text] [Related]
13. Mediatory role of NMDA, AMPA/kainate, GABA
Motaghinejad M; Motevalian M; Fatima S
Life Sci; 2017 Jun; 179():37-53. PubMed ID: 28082019
[TBL] [Abstract][Full Text] [Related]
14. MK-801 enhances gabaculine-induced loss of the righting reflex in mice, but not immobility.
Irifune M; Katayama S; Takarada T; Shimizu Y; Endo C; Takata T; Morita K; Dohi T; Sato T; Kawahara M
Can J Anaesth; 2007 Dec; 54(12):998-1005. PubMed ID: 18056209
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate and MK-801, an N-methyl-d-aspartate receptor antagonist: shared biological properties.
Husson I; Mesplès B; Medja F; Leroux P; Kosofsky B; Gressens P
Neuroscience; 2004; 125(1):163-70. PubMed ID: 15051155
[TBL] [Abstract][Full Text] [Related]
16. Prenatal treatment of Down syndrome: a reality?
Guedj F; Bianchi DW; Delabar JM
Curr Opin Obstet Gynecol; 2014 Apr; 26(2):92-103. PubMed ID: 24573065
[TBL] [Abstract][Full Text] [Related]
17. Bioenergetic homeostasis decides neuroprotection or neurotoxicity induced by volatile anesthetics: a uniform mechanism of dual effects.
Zhang J; Zhou W; Qiao H
Med Hypotheses; 2011 Aug; 77(2):223-9. PubMed ID: 21550179
[TBL] [Abstract][Full Text] [Related]
18. The AMPA receptor positive allosteric modulator, S18986, is neuroprotective against neonatal excitotoxic and inflammatory brain damage through BDNF synthesis.
Destot-Wong KD; Liang K; Gupta SK; Favrais G; Schwendimann L; Pansiot J; Baud O; Spedding M; Lelièvre V; Mani S; Gressens P
Neuropharmacology; 2009 Sep; 57(3):277-86. PubMed ID: 19501111
[TBL] [Abstract][Full Text] [Related]
19. Environmental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain.
Olney JW; Farber NB; Wozniak DF; Jevtovic-Todorovic V; Ikonomidou C
Environ Health Perspect; 2000 Jun; 108 Suppl 3(Suppl 3):383-8. PubMed ID: 10852832
[TBL] [Abstract][Full Text] [Related]
20. Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.
Louzada PR; Paula Lima AC; Mendonca-Silva DL; Noël F; De Mello FG; Ferreira ST
FASEB J; 2004 Mar; 18(3):511-8. PubMed ID: 15003996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
